Current Report Filing (8-k)
September 25 2020 - 5:10PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of
1934
Date of Report (Date of earliest event reported)
September 25,
2020
cbdMD, Inc.
(Exact name of registrant as specified in its charter)
North Carolina
|
001-38299
|
47-3414576
|
(State or other jurisdiction of incorporation or
organization)
|
(Commission File Number)
|
(I.R.S. Employer Identification No.)
|
8845
Red Oak Boulevard, Charlotte, NC
|
|
28217
|
(Address
of principal executive offices)
|
|
(Zip
Code)
|
Registrant's
telephone number, including area code: (704) 445-3060
________________________________
(Former name or former address, if changed since last
report)
Check
the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2.
below):
☐ Written communications pursuant to Rule 425 under
the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under
the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities
registered pursuant to Section 12(b) of the Act:
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
common
|
YCBD
|
NYSE American
|
8.0% Series A Cumulative Convertible Preferred Stock
|
YCBD PR A
|
NYSE American
|
Indicate by check mark whether the registrant is an emerging growth
company as defined in in Rule 405 of the Securities Act of 1933
(§230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (§240.12b-2 of this
chapter).
Emerging growth company ☑
If an
emerging growth company, indicate by checkmark if the registrant
has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided
pursuant to Section 13(a) of the Exchange Act. ☐
Item
8.01 Other Events.
cbdMD,
Inc. (the “Company”) recently determined the eCommerce
platform underlying its online retail sales webpage, cbdmd.com, was modified by an
unauthorized third-party to include malicious code. The malicious
code created a risk that customer-input elements on the webpage may
have been skimmed by an unauthorized third-party. The Company
notified federal law enforcement and has been cooperating with
their investigation. Although the Company cannot confirm that
customer information was acquired, on or about September 28, 2020
the Company will begin providing notice of the incident to the
customers who may be at risk and is offering to provide one year of
identity monitoring without cost to them. The Company has
implemented additional technical security measures designed to
prevent similar incidents from occurring in the
future.
SIGNATURES
Pursuant to the
requirements of the Securities Exchange Act of 1934, the registrant
has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
|
cbdMD, Inc.
|
|
|
|
Date: September 25, 2020
|
By:
|
/s/ Mark S. Elliott
|
|
|
Mark S. Elliott, Chief Financial Officer and Chief Operating
Officer
|
cbdMD (AMEX:YCBD)
Historical Stock Chart
From Aug 2024 to Sep 2024
cbdMD (AMEX:YCBD)
Historical Stock Chart
From Sep 2023 to Sep 2024